Lenalidomide market to reach $17.83 billion by 2030 at 6.7% CAGR, driven by increase in prevalence of blood cancer cases.
Read More
Leiomyosarcoma drug market to reach $1.76 billion by 2030 at 8.3% CAGR, driven by growing investment in oncology research.
Read More
Lecithin supplements market to reach $3.22 billion by 2030 at 9.2% CAGR, driven by growing demand for dietary supplements.
Read More
The Laxatives market size is expected to reach $12.49 billion in 2030 at a CAGR of 8.2%, driven by rising gastric disorder prevalence.
Read More
The Lateral Epicondylitis Treatment market size is expected to reach $2.98 billion in 2030 at a CAGR of 4.9%, driven by growth in sports activities.
Read More
The Late Stage Chronic Kidney Disease Drugs market size is expected to reach $13.59 billion in 2030 at a CAGR of 11.7%, driven by CKD prevalence.
Read More
The Lactose Intolerance Treatment market size is expected to reach $49.13 billion in 2030 at a CAGR of 7.4%, driven by rising global population.
Read More
The Lactation Support Supplements market size is expected to reach $1.34 billion in 2030 at a CAGR of 7.0%, driven by working mothers growth.
Read More
The Lab Automation in Drug Discovery market size is expected to reach $8.72 billion in 2030 at a CAGR of 5.2%, driven by precision medicine demand.
Read More
The global Kinase Inhibitors market size is expected to reach $94.01 billion in 2030 at a CAGR of 6.8%, driven by rising cancer incidence.
Read More